Literature DB >> 25052968

Clinical presentations of acute leukemia.

Faseeh Shahab1, Fazli Raziq1.   

Abstract

OBJECTIVE: To document the clinical presentation and epidemiology of various types of acute leukemia with their respective referral source at a tertiary level centre in Peshawar. STUDY
DESIGN: An observational study. PLACE AND DURATION OF STUDY: Department of Pathology, Hayatabad Medical Complex (HMC), Peshawar, from January 2011 to May 2012.
METHODOLOGY: A total of 618 bone marrow biopsy reports were reviewed. All biopsy reports labeled as acute leukemia were reviewed for age, gender, address, referring unit, diagnosis on bone marrow examination, presenting complaints, duration of illness and findings of clinical examination.
RESULTS: Ninety-two patients were diagnosed as suffering from acute leukemias (15%). ALL was most prevalent (46%), followed by AML (38%) and undifferentiated acute leukemia (16%). Males were affected more compared to females (60% vs. 40%). ALL and AML were predominant in pediatric (64%) and adults (77%) patients respectively. Patients from Afghanistan accounted for 33% of all cases followed by Peshawar (14%). Fever (77%), pallor (33%) and bleeding disorders (23%) were the main presenting complaints. Enlargement of liver, spleen and lymph nodes together was associated with ALL compared with AML (p = 0.004).
CONCLUSION: ALL-L1 and AML-M4 were the most common sub-types. Fever, pallor and bleeding disorders were the main presenting complaints. Enlargement of liver, spleen and lymph nodes was more frequently associated with ALL compared to AML.

Entities:  

Mesh:

Year:  2014        PMID: 25052968     DOI: 07.2014/JCPSP.472476

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  6 in total

1.  Clinical characteristics of childhood cancer in emergency room in a tertiary hospital in Pakistan.

Authors:  Amna Jawaid; Khubaib Arif; Nick Brown; Zehra Fadoo
Journal:  World J Emerg Med       Date:  2016

2.  APC2 and CYP1B1 methylation changes in the bone marrow of acute myeloid leukemia patients during chemotherapy.

Authors:  Yongming Xia; Qingxiao Hong; Xiaoying Chen; Huadan Ye; Lili Fang; Annan Zhou; Yuting Gao; Danjie Jiang; Shiwei Duan
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

3.  Combined efficacy of Cinnamomum zeylanicum and doxorubicin against leukemia through regulation of TRAIL and NF-kappa B pathways in rat model.

Authors:  Sidra Bukhari; Muhammad Hamid Siddique; Anum Naeem; InamUllah Khan; Zain Ali; Asiya Essa; Falak Fazal; Riffat Aysha Anis; Lukas Moran; Aneesa Sultan; Iram Murtaza; Petr Vanhara; Mariam Anees
Journal:  Mol Biol Rep       Date:  2022-05-17       Impact factor: 2.742

4.  Association between the methylation status of the MGMT promoter in bone marrow specimens and chemotherapy outcomes of patients with acute myeloid leukemia.

Authors:  Qingxiao Hong; Xiaoying Chen; Huadan Ye; Annan Zhou; Yuting Gao; Danjie Jiang; Xiaodong Wu; Bingru Tian; Youfen Chen; Ming Wang; Jiping Xie; Yongming Xia; Shiwei Duan
Journal:  Oncol Lett       Date:  2016-03-09       Impact factor: 2.967

5.  Outcomes of 1st Remission Induction Chemotherapy in Acute Myeloid Leukemia Cytogenetic Risk Groups

Authors:  Samreen Zehra; Rahela Najam; Tasneem Farzana; Tahir Shamsi
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01

6.  Hyperuricemia might be an early manifestation of undiagnosed adult leukemia in a population-based cohort study.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Biomedicine (Taipei)       Date:  2020-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.